Kennett Square, PA, United States of America

Elizabeth C Hsia

This inventor holds 7 USPTO granted patents and 13 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Janssen Biotech, Inc.. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elizabeth C Hsia. Retrieved from https://idiyas.com/inventor/elizabeth-c-hsia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 13)

% Patents Active = 71.4

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 1 (Patent Applications = 7)

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 9(Granted Patents)

Company Filing History:

7 out of 433

Janssen Biotech, Inc.

patents

Years Active: 2019-2025

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12404324 - Safe and effective method of treating psoriatic arthritis with anti-IL23 specific antibody (2025-09-02),

2. 12291566 - Anti-TNF antibodies, compositions, and methods for the treatment of active Ankylosing Spondylitis (2025-05-06),

3. 12122824 - Anti-TNF antibodies, compositions, and methods for the treatment of active ankylosing spondylitis (2024-10-22),

4. 11124565 - Method for treating pre-type 1 diabetes in a human subject (2021-09-21),

5. 11041020 - Methods for the treatment of active Psoriatic Arthritis (2021-06-22),

6. 11014982 - Anti-TNF antibodies, compositions, and methods for the treatment of active ankylosing spondylitis (2021-05-25),

7. 10465003 - Anti-TNF antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes (2019-11-05),

Title: Innovations by Elizabeth C Hsia

Introduction

Elizabeth C Hsia is a prominent inventor based in Kenneth Square, PA (US). She has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases. With a total of seven patents to her name, her work has had a profound impact on patient care and treatment methodologies.

Latest Patents

Among her latest patents is a safe and effective method of treating psoriatic arthritis with an anti-IL23 specific antibody. This method involves administering an IL-23 specific antibody, such as guselkumab, in a clinically proven safe and effective amount. Patients receiving this treatment have shown significant improvements in various clinical measures over time. Another notable patent focuses on anti-TNF antibodies, compositions, and methods for the treatment of active Ankylosing Spondylitis. This invention utilizes specific antibody compositions for the safe and effective treatment of this condition.

Career Highlights

Elizabeth C Hsia is currently associated with Janssen Biotech, Inc., where she continues to innovate and develop new treatment options. Her work is characterized by a commitment to improving patient outcomes through scientific research and development.

Collaborations

Some of her notable coworkers include Diane Deborah Harrison and Lee-Lian Kim, who contribute to the collaborative efforts in advancing medical treatments.

Conclusion

Elizabeth C Hsia's contributions to the field of medicine through her patents and innovative approaches have made a significant difference in the treatment of autoimmune diseases. Her work exemplifies the impact of dedicated research and collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.